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SUMMARY
High numbers of eosinophils are observed in parasitic infec-
tions and allergic diseases, where they are proposed to be
terminally differentiated effector cells that play beneficial
role in host defence, or cause harmful inflammatory
response. Eosinophils have been associated with killing of
schistosomulae in vitro, but there is growing evidence that
eosinophils can play additional immuno-regulatory role.
Here, we report results of a study that examines peripheral
blood mononuclear cell (PBMC) cytokine responses to
Schistosoma mansoni adult worm antigen (SWA) when
stimulated alone or enriched with autologous
eosinophils.Production of the Th-2 type cytokines interleukin
(IL)-4, IL-5 and IL-13 was lower (P = 0017, 0018 and
<0001, respectively) in PBMC + eosinophil cultures than
in PBMC-only cultures stimulated with SWA. Substantial
levels of IL-13, IL-10, interferon gamma and tumour necro-
sis factor alpha were recorded in cultures of eosinophils, but
none of these cytokines showed significant association with
the observed eosinophil-induced drop in cytokine responses
of PBMC. Transwell experiments suggested that the
observed effect is due to soluble mediators that downmodu-
late production of Th-2 type cytokines.This study shows that
eosinophils may down-modulate schistosome-specific Th-2
type cytokine responses in S. mansoni-infected individuals.
The mechanism of this immune modulation remains to be
elucidated.
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INTRODUCTION
Eosinophils are regarded as terminally differentiated non-
replicating effector cells that accumulate in a number of
health disorders, including parasitic infections and allergic
diseases (1), where they may play a beneficial role in the
host defence against helminth infections (2), or cause a
harmful inflammatory response (3), respectively. Epidemi-
ological studies in schistosomiasis-endemic populations
have shown that high peripheral blood eosinophil counts
are associated with resistance to re-infection with schisto-
somes (4–7), which supports a role for eosinophils in par-
asite immunity. In particular, the effector function
involving cross-linking of IgE bound to the high affinity
receptor FCeRIb (8,9) allows eosinophils to mediate both
direct and indirect killing of schistosomulae in vitro
(10–14).
There is growing evidence that eosinophils play an addi-
tional role of immunoregulation (15) in both adaptive and
innate immunity to parasitic infections. Mature human
eosinophils express major histocompatibility (MHC) class
II (16) and the necessary co-stimulatory molecules (17) for
antigen presentation and have been demonstrated to func-
tion as antigen-presenting cells in co-cultures (18). Fur-
thermore, evidence of the ability of eosinophils to regulate
T-cell function has been reviewed (15,19), highlighting the
role of eosinophils in both innate and adaptive immunity.
Eosinophils express both Th-1 (IFN-c, IL-2) and Th-2
(IL-4, IL-5, IL-13) cytokines (20–22). In mice infected
with Schistosoma mansoni, eosinophils have been associ-
ated with Th-2 polarization by IL-4 production (23) and
can be a dominant source of Th-2 type cytokines (24).
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In humans, a study in S. mansoni endemic populations
in Uganda suggested that eosinophils may be an impor-
tant cellular source of Th-2 type cytokines, in particular
IL-5 (25). Associations between plasma IL-5 and the num-
ber of eosinophils in the peripheral circulation were noted,
and these parameters were influenced by praziquantel
treatment against the schistosomes (25). An increase in
plasma IL-5 was observed one day post-treatment and was
associated with a transient decline in circulating eosino-
phils, presumably due to sequestration of the eosinophils
to the sites of the dying worms. The transient decline in
number of eosinophils in peripheral blood may also be
attributed to IL-5-induced adhesion of eosinophils to the
vascular endothelium (26,27).
Taken together, these immuno-epidemiological and
experimental studies of schistosomiasis underscore the role
of eosinophils in the modulation of immune responses in
parasitic infections, and yet despite this, the underlying
mechanisms are not well understood. Here, we report
results regarding the effects of human eosinophils on
peripheral blood mononuclear cells (PBMC) from S. man-
soni-infected individuals, exploring, in vitro, the effects of
eosinophils on PBMC cytokine production in response to
S. mansoni adult worm antigen.
MATERIALS AND METHODS
Study setting, subjects and samples
This study was conducted at the Uganda Virus Research
Institute (UVRI) and Kigungu Health Centre IV, Wakiso
district, in Uganda in 2011–2013. Schistosoma mansoni-
infected adults living in Kigungu village on the shores of
Lake Victoria were identified following a stool screening
exercise by the Vector Control Division of the Ministry of
Health. The study was carried out in two phases. Partici-
pants were enrolled to participate in the study after provid-
ing written informed consent. In the first phase, we obtained
samples from 42 participants to explore the effects of eosino-
phils on PBMC responses. Of these, 31 were suitable for eosi-
nophil isolation (based on eosinophil numbers >04 9 103
cells per lL). After eosinophil isolation, 26 individuals had
eosinophil purities of ≥90% and were considered in the anal-
ysis. Of these, 19 participants provided follow-up blood sam-
ples at 3 weeks after praziquantel treatment. In the second
phase, we obtained samples from 30 participants to explore
the possible mechanisms by which eosinophils might influ-
ence PBMC responses. Of these, samples obtained from 19
participants were suitable for analysis. All participants were
treated with a single dose of praziquantel at 40 mg/kg body
weight. Individuals identified with soil transmitted helminth
infections were treated with albendazole.
Ethics statement
Ethical clearance to conduct this study was obtained from
the Science and Ethics Committee of Uganda Virus
Research Institute and the Uganda National Council for
Science and Technology. The participants provided written
informed consent.
PBMC and eosinophil isolation
Blood drawn in heparin was processed for PBMC and
eosinophil isolation. PBMC was isolated by histopaque
gradient centrifugation according to a standard proto-
col. Eosinophils were isolated by negative selection
using a commercial Eosinophil Isolation kit (MAC Mil-
tenyi Biotec, Bergisch Gladbach, Germany) according to
the manufacturer’s instructions and as described by
Munoz and Left (28). The kit comprised a biotinylated
antibody cocktail (130-092-010 Miltenyi Biotec, Berisch
Gladbach, Germany) and magnetic antibiotin micro
beads (130-092-010 Miltenyi Biotec). LS+ selection col-
umns (130-042-401 Miltenyi Biotec) were used, mounted
in the MidiMACS Separation Unit magnet (130-042-
102, Miltenyi Biotec); separation was performed using
autoMacs buffer (130-091-221, Miltenyi Biotec). The
isolated eosinophil fraction was analysed by flow
cytometry to confirm purity. Purified eosinophils were
fixed by suspending them in 4% paraformaldehyde for
5 min at room temperature, washed twice in 01%BSA
PBS FACS buffer and resuspended in 200 lL of 01%
saponin (Sigma-Aldrich. St. Louis, Missouri USA)/
HBSS (14175129, Invitrogen, California USA) buffer for
30 min in the dark at room temperature. The cells were
washed once in FACS buffer, resuspended in 200 lL
FACS buffer, and acquisition carried out on an LSRII
flow cytometer (BD Biosciences, San Jose, CA USA)
within 12 h of processing the sample. The acquired data
were analysed using FLOWJO software (Versions 9 Tree
Star Inc. Ashland OR, USA).
The purity of the eosinophil fraction was determined by
applying forward and side scatter analysis (Figure S1) and
identified as previously described by Levigne et al. (29);
the eosinophils population stand out clearly due to their
granularity.
Cell culture stimulation
Cell culture stimulation was set up in duplicate on 96-well
round-bottomed cell culture plates (TC Microwell, NUNC
A/S, Roskelde, Denmark) in which 8 9 105 PBMC alone,
8 9 105 PBMC + 2 9 105 eosinophils or 2 9 105 eosino-
phils alone were stimulated with either S. mansoni adult
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worm antigen (SWA) or left unstimulated. The stimulation
was performed in a final volume of 200 lL per well. The
final concentration of the SWA was 10 lg/mL. The plates
were incubated at 37°C and 5% CO2 for 24 h. This timing
was arrived at following optimization experiments, which
showed that after 24 h, the proportion of viable cells
dropped dramatically. Culture supernatants were harvested
and incubated with viral inactivation buffer (003% tribu-
tyl phosphate and 1% Tween 80 (Sigma)) at room temper-
ature for one hour before storage at 80°C until needed
for analysis.
Cytokine assays
Culture supernatants were examined for the concentration
of interleukin (IL)-4, IL-5, IL-10, IL-13, interferon gamma
(IFN-c) and tumour necrosis factor alpha (TNF-a). The
cytokines were measured by ELISA using commercial
OptEIA Kits (BD PharMingen, San Jose USA) except
IL13, which was measured using antibody pairs (BD
PharMingen), with standards from the National Institute
for Biological Standards and Controls (NIBSC, UK). The
sensitivity of the assay and cut-off for a positive response
was the lowest standard detectable, which was 78 pg/mL
for IL-4, IL-5, IL-10 and IL-13, 29 pg/mL for IFN-c and
93 pg/mL for TNF-a.
Data analysis
To obtain specific responses, cytokine concentrations in
unstimulated wells were subtracted from concentrations in
stimulated wells. Net cytokine concentrations were com-
pared between the cell culture setups using Wilcoxon
signed-rank paired sample test.
RESULTS
In the first phase of the study (n = 26), we compared cyto-
kine production between PBMC cultures, PBMC + eosino-
phil co-cultures and eosinophil alone cultures. We
observed no significant spontaneous cytokine production
in any of the cell culture setups (data not shown). When
we examined cytokine production in response to SWA,
levels of Th-2 type cytokines (IL-4, IL-5 and IL-13) were
highest in cultures of PBMC alone, significantly lower in
PBMC + eosinophil co-culture supernatants and lowest in
cultures of eosinophils alone (Figure 1a–c). By contrast,
we observed low TNF-a production in response to SWA
in PBMC cultures but substantial responses in PBMC +
eosinophils co-cultures, and similar responses for eosino-
phils alone (Figure 1f). No differences in IFN-c or IL-10
production were observed.
Follow-up blood samples obtained at 3 weeks after
praziquantel were similarly examined. Cytokine responses
were boosted following praziquantel treatment, and the
associations observed between the cell stimulation cultures
were similar as observed for enrolment samples
(Figure S2).
Possible mechanisms of PBMC and eosinophil interac-
tion include direct cell-to-cell contact or through cyto-
kine/chemokine signalling. To explore these possible
mechanisms, samples obtained at 3 weeks after prazi-
quantel treatment from 19 participants in the second
phase were stimulated in 96-well round-bottomed trans-
well cell culture plates (CLS3381, Corning HTS Trans-
well, Sigma-Aldrich, St. Louis Missouri, USA) where
eosinophils and PBMC were separated by a 04 lm pore
size polycarbonate (PC) trans-membrane. We focused on
IL-5 and IL-13 cytokine responses, which had shown
strong effects in the first phase of the study. Figure 1g, h
shows IL-5 and IL-13 responses following stimulation of
PBMC alone or PBMC + eosinophils in co-culture, or in
trans-wells separated by a trans-membrane. Consistent
with our initial findings (Figure 1b, c), levels of IL-5 and
IL-13 in response to SWA were lower in PBMC + eosino-
phil co-cultures than in PBMC alone cultures. Similarly,
levels of IL-5 and IL-13 were lower in PBMC + eosino-
phils in trans-well cultures than in PBMC alone cultures.
Of note, the cytokine levels were not significantly differ-
ent between PBMC + eosinophil co-cultures and PBMC
+ eosinophils in trans-well cultures. This suggests that the
observed differences in cytokine levels between PBMC
and PBMC + eosinophil cultures were due to soluble
mediators that exert a down-modulation effect on the Th-
2 type cytokines produced by PBMC.
DISCUSSION
The main aim of this study was to explore the possible
regulatory functions of eosinophils in helminth infections.
This we did by looking at the cytokine production in vitro
in response to schistosome adult worm antigen (SWA)
among cells from individuals infected with S. mansoni. We
found that eosinophils alone produced low levels of IL-4
and IL-5 in this assay and that PBMCs enriched with
autologous eosinophils had reduced Th-2 cytokine
production compared to cultures of PBMC without
eosinophils.
Eosinophils are a recognized source of Th-2 type
cytokines (24), so our observation that eosinophils alone
showed limited production of IL-4 and IL-5 in response
to SWA was surprising. However, substantial IL-13,
IL-10, IFN-c and TNF production was detectable in a
number of individuals. This was consistent with reports
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Figure 1 Cytokine levels in supernatants
from PBMC, PBMC+ eosinophils
(PBMC+Eos) or eosinophils in response to
S. mansoni adult worm antigen (SWA).
Shown are (a) IL-4, (b) IL-5, (c) IL1-3,
(d) IL-10, (e) IFN-c and (f) TNF-a
responses to SWA. The plots show cytokine
production in PBMC, PBMC + eosinophils
(Eos) or eosinophils alone. Graphs g and h
show levels of IL-5 and IL-13, respectively,
in supernatants from PBMC or PBMC +
eosinophils in co-culture or trans-well
stimulation with S. mansoni adult worm
antigen (SWA). PBMC and eosinophils in
transwells were separated by a 04-lm pore
size polycarbonate (PC) trans-membrane.
The P-values are the Wilcoxon signed-rank
paired samples test comparisons.
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that eosinophils are a source of both pro-inflammatory
and immune regulatory cytokines (30–32) with IL-13,
IFN-c and TNF-a most abundant (30). Most of the
cytokines produced by eosinophils exist preformed,
stored within the crystalloid granules and are readily
released on activation. Release of the contents of the
crystalloid granules has been reported to occur in four
distinct modes, namely classical exocytosis, compound
exocytosis, piecemeal degranulation and cytolysis (33).
In interpreting our findings, it is important to recognize
that differential release (and loss) of cytokines may have
occurred during the process of eosinophil isolation. This
could explain the low levels of some cytokines in the
eosinophil culture supernatants, and levels of cytokine
measured in our assay may have been lower than those
naturally available from the eosinophils. On the
other hand, eosinophils have been demonstrated to
express the inhibitory receptor IRp60, which when
activated, would lead to decreased release of cytokines
(34) and this may partly explain the low levels of
cytokines from eosinophils.
Following stimulation with SWA, we observed low levels
of Th-2 type cytokines (IL-4, IL-5 and IL-13) in super-
natants of PBMC enriched with autologous eosinophils
compared to the supernatants of PBMC without eosino-
phils. This effect was not seen for IL10, IFN-c and TNF-
a responses, suggesting that only type two cytokines were
influenced. Most striking is that this finding contradicts
the studies from allergic individuals (35), where eosino-
phils have been shown to promote both type one and type
two cytokine production. Our study differs from Liu’s on
two accounts: our study involved samples from S. man-
soni-infected individuals and looked at schistosome anti-
gen-specific responses of PBMC, and Liu’s study involved
samples from allergic subjects and looked at CD4
responses to staphylococcal enterotoxin B (SEB). Our
findings also contradict studies in mice that showed eosi-
nophils to preferentially enhance Th-2 type cytokine pro-
duction by CD4 cells (36,37).
Eosinophilia is more common among individuals in
tropical Africa (38–41) than elsewhere (42–44), and
although the mechanism behind eosinophilia among the
people in tropical Africa is not well understood, it is
thought to be due to exposure to the array of parasites
(45). It is plausible that the eosinophilia observed in hel-
minth infections may be dictated by the body’s need of
both their effector and regulatory functions.
Whereas in temperate places that lack helminth infec-
tion, eosinophilia occurs mainly in allergic diseases (1),
in tropical Africa, levels of eosinophilia are closely asso-
ciated with the parasite burden and there is a low inci-
dence of allergic diseases (46,47). It is plausible that
eosinophils of individuals with a helminth infection are
fundamentally different in their biological functions
from those of uninfected individuals. Eosinophils of
individuals with a helminth infection may have regula-
tory functions that help to minimize allergic responses,
functions which are not exhibited by eosinophils from
individuals without a helminth infection, such as those
with allergies. This may explain the finding of the cur-
rent study that is divergent from those previously
reported by Liu and colleagues (35). Indeed, a recent
review by Davoine and Lacy (32) describing the various
chemokines, cytokines and growth factors released by
eosinophils underscores the fact that the role of eosino-
phils in immunity is more complex than previously
thought. Eosinophils remain a fascinating area for more
research.
In our current study, we did not fully explore the mech-
anisms by which eosinophils modulated PBMC responses.
However, the trans-well experiment indicates that the
effect is likely to be mediated by soluble factors produced
by eosinophils as opposed to cell-to-cell contact. Eosino-
phils produce various cytokines and chemokines known to
influence both innate and adaptive immune responses (48);
however, the exact player for the effects on PBMC
observed in our current study still remains a question to
be answered.
Thus, based on findings of our study and the previous
reports, we hypothesize that cytokines and chemokines
produced by eosinophils could be responsible for the
reduced cytokine responses when PBMC was cultured
together with autologous eosinophils. The nature and
mode of the postulated mediators remain to be explored.
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SUPPORTING INFORMATION
Additional Supporting Information
may be found online in the support-
ing information tab for this article:
Figure S1. Flowcytometry analysis
showing the granulocytes. Based on
granularity and auto-fluorescence, the
eosinophils fraction is well defined
from other granulocytes.
Figure S2. Cytokine levels in super-
natants of PBMC, PBMC+
eosinophils or eosinophils in response
to S. mansoni adult worm antigen
(SWA) measured at 3 weeks after
praziquantel treatment.
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